Cargando…
The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients
INTRODUCTION: Despite decreasing consumption by general populations, use of synthetic cannabinoid receptor agonists (SCRAs) persists in some marginalised groups, including those who use other substances. This article explores SCRA consumption in an Australian cannabis treatment sample, comparing tho...
Autores principales: | Jackson, Melissa A., Brown, Amanda L., Johnston, Jennifer, Clancy, Richard, McGregor, Iain, Bruno, Raimondo, Lintzeris, Nick, Montebello, Mark, Luksza, Jennifer, Bowman, Jenny, Phung, Nghi, Allsop, Dave, Dunlop, Adrian J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314558/ https://www.ncbi.nlm.nih.gov/pubmed/34311790 http://dx.doi.org/10.1186/s42238-021-00091-z |
Ejemplares similares
-
Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol
por: Bhardwaj, Anjali K., et al.
Publicado: (2018) -
Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder
por: Mills, Llewellyn, et al.
Publicado: (2022) -
Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016–2019
por: Black, Emma, et al.
Publicado: (2022) -
Analysis of Cannabis Seizures in NSW, Australia: Cannabis Potency and Cannabinoid Profile
por: Swift, Wendy, et al.
Publicado: (2013) -
Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV)
por: Mersiades, Antony J, et al.
Publicado: (2018)